Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Cash from Investing Activities: 2015-2020

Historic Cash from Investing Activities for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -$900,000.

  • Outlook Therapeutics' Cash from Investing Activities rose 100.00% to -$1 in Q3 2019 from the same period last year, while for Sep 2019 it was -$437,307, marking a year-over-year increase of 84.28%. This contributed to the annual value of -$900,000 for FY2020, which is 105.81% down from last year.
  • As of FY2020, Outlook Therapeutics' Cash from Investing Activities stood at -$900,000, which was down 105.81% from -$437,307 recorded in FY2019.
  • Over the past 5 years, Outlook Therapeutics' Cash from Investing Activities peaked at -$292,086 during FY2017, and registered a low of -$2.8 million during FY2018.
  • For the 3-year period, Outlook Therapeutics' Cash from Investing Activities averaged around -$1.4 million, with its median value being -$900,000 (2020).
  • In the last 5 years, Outlook Therapeutics' Cash from Investing Activities surged by 87.53% in 2016 and then tumbled by 852.16% in 2018.
  • Yearly analysis of 5 years shows Outlook Therapeutics' Cash from Investing Activities stood at -$1.1 million in 2016, then spiked by 73.40% to -$292,086 in 2017, then tumbled by 852.16% to -$2.8 million in 2018, then skyrocketed by 84.28% to -$437,307 in 2019, then tumbled by 105.81% to -$900,000 in 2020.